Search - tctmd.com

Displaying 421 - 440 of 473

Sort: Relevancy | Date

News Industry News

Boston Scientific to Acquire BridgePoint Medical, Inc.

September 19, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Daily News

Clot Retrieval Devices Show Improved Results in Acute Ischemic Stroke Patients

Jason Kahn

August 31, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Daily News

Thrombectomy Device Helps Revascularize Acute Stroke Patients

August 21, 2012

News Daily News

PARTNER Analysis: Vascular Complications Common in Transfemoral TAVR

Jason Kahn

August 14, 2012

News Industry News

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

August 07, 2012

News Daily News

Meta-analysis: Endovascular Therapy Improves Outcomes in Acute Ischemic Stroke

Jason Kahn

July 24, 2012

News Industry News

Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program

June 21, 2012

News Daily News

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

June 12, 2012

News Industry News

Medtronic Launches Endurant® II AAA Stent Graft System in U.S.

June 06, 2012

News Industry News

Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions

June 04, 2012

News Industry News

Medtronic Expands Availability of Valiant® Captivia® Stent Graft in Major Global Markets

May 08, 2012

News Conference News ACC 2012

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Yael L. Maxwell

March 27, 2012

News Daily News

Tanto el Coste como la Calidad del Tratamiento de la EAP Depende del Personal Médico al Cargo

Yael L. Maxwell

March 06, 2012

News Daily News

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

L.A. McKeown

March 06, 2012

News Daily News

PAD Treatment Cost, Quality Dependent on Provider

Yael L. Maxwell

March 06, 2012

News Industry News

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 06, 2012

Advertisement

Boston Scientific to Acquire BridgePoint Medical, Inc.

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Clot Retrieval Devices Show Improved Results in Acute Ischemic Stroke Patients

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Thrombectomy Device Helps Revascularize Acute Stroke Patients

PARTNER Analysis: Vascular Complications Common in Transfemoral TAVR

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Meta-analysis: Endovascular Therapy Improves Outcomes in Acute Ischemic Stroke

Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

Medtronic Launches Endurant® II AAA Stent Graft System in U.S.

Hansen Medical Receives FDA 510(k) Clearance for its Magellan™ Robotic System for Peripheral Vascular Interventions

Medtronic Expands Availability of Valiant® Captivia® Stent Graft in Major Global Markets

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Tanto el Coste como la Calidad del Tratamiento de la EAP Depende del Personal Médico al Cargo

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

PAD Treatment Cost, Quality Dependent on Provider

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content